TARO-ZOLEDRONIC ACID CONCENTRATE
TARO PHARMACEUTICALS INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of TARO-ZOLEDRONIC ACID CONCENTRATE in Canada?
Yes. TARO-ZOLEDRONIC ACID CONCENTRATE 4MG has an active shortage reported to Health Canada (last updated September 18, 2026).
Why is TARO-ZOLEDRONIC ACID CONCENTRATE not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will TARO-ZOLEDRONIC ACID CONCENTRATE be available again?
The manufacturer's estimated resolution date is October 2, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
VAL-ZOLEDRONIC ACID
BAUSCH HEALTH, CANADA INC.
ZOLEDRONIC ACID CONCENTRATE
APOTEX INC
ZOLEDRONIC ACID - Z
SANDOZ CANADA INCORPORATED
ACT ZOLEDRONIC ACID CONCENTRATE
ACTAVIS PHARMA COMPANY
ZOLEDRONIC ACID FOR INJECTION CONCENTRATE
DR REDDY'S LABORATORIES LTD
JAMP-ZOLEDRONIC ACID
JAMP PHARMA CORPORATION
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02415186
Strength
4MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from TARO PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
2% · DIN 02247560
DIN 02315033
DIN 02230251
DIN 02304457
0.05% · DIN 00716618
0.1% · DIN 00716626
0.1% · DIN 00716634
0.05% · DIN 00716642
0.1% · DIN 00716650
1% · DIN 00812382
2% · DIN 00812374
1% · DIN 00812366